Two initiatives in the Department of Neurology should help in the effort to take research from bench to bedside, a key strategy for BioMed 21. Learn more about each of the projects in the following story from the St. Louis Post-Dispatch and two School of Medicine press releases.
New Hope Center will focus brain power on neurological diseases
Singer songwriter Chris Hobler has teamed up with the School of Medicine to help create a new center dedicated to neurological research. Hobler suffers from ALS, commonly referred to as Lou Gehrig’s disease. Read more in the following article written by Tina Hesman of the St. Louis Post-Dispatch.
Center combines area resources to study neurological diseases
Two St. Louis organizations have teamed up to create the Hope Center for Neurological Disorders, a unique collaboration dedicated to basic science research on a broad spectrum of nervous system conditions. A reception to celebrate the new initiative will take place at 4 p.m. on Tuesday, Oct. 5 at the Center for Advanced Medicine.
New unit devoted to clinical neurology research
Clinical trials testing treatments for neurological disorders such as Parkinson’s disease and epilepsy soon will be conducted under one roof at the School of Medicine, adding critical mass to the neuroclinical research program and convenience for patients enrolled in clinical trials.